-- Announcement on Resolutions of the 16th Meeting of the 10th Board of Supervisors
Securities code: 600252 Securities abbreviation: Zhongheng Group Announcement number: Lin 2025-76
Guangxi Wuzhou Zhongheng Group Co., Ltd.
Announcement of Resolutions of the 16th Meeting of the 10th Supervisory Board
The Company's Supervisory Committee and all supervisors guarantee that there are no false records, misleading statements or major omissions in this announcement, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
1. Convening of Supervisory Board Meetings
The notice and proposal materials for the 16th meeting of the 10th Supervisory Board of Guangxi Wuzhou Zhongheng Group Co., Ltd. (hereinafter referred to as the "Company" or "Zhongheng Group") were sent by email on August 23, 2025. The meeting was held on August 28, 2025 by on-site and communication means. Mr. Liu Mingliang, Chairman of the Supervisory Board, participated and presided over the meeting by means of communication, and Supervisor Ms. Wang Jian attended the on-site meeting. There were 3 supervisors who should participate in the voting at the meeting, and 3 supervisors actually participated in the voting. The convening and holding of the meeting complied with the relevant provisions of the Company Law, the Articles of Association and the Rules of Procedure of the Company's Supervisory Board.
2. Review status of the Supervisory Board meeting
The meeting reviewed and voted by registered vote to adopt the following proposals and matters:
(1) The meeting reviewed and approved the "2025 Semi-annual Report of Guangxi Wuzhou Zhongheng Group Co., Ltd. (Full Text and Summary)";
The company's Board of Supervisors reviewed the 2025 semi-annual report and issued the following review opinions:
The preparation and review procedures of the "Zhongheng Group 2025 Semi-Annual Report" comply with the provisions of laws and regulations, normative documents, the "Articles of Association" and the company's internal management system.
The content and format of the "Zhongheng Group 2025 Semi-Annual Report" comply with various regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange. The information contained truly reflects the company's business management and financial status and other matters during the reporting period from all aspects; the disclosed content is true, accurate and complete, and does not contain any false records, misleading statements or major omissions.
The Board of Supervisors did not find that any personnel involved in the preparation and review of the "Zhongheng Group's 2025 Semi-Annual Report" violated confidentiality regulations.
For details of the specific content of this report, please refer to the "2025 Semi-Annual Report of Guangxi Wuzhou Zhongheng Group Co., Ltd." and its summary disclosed by the company on the Shanghai Stock Exchange website (www.sse.com.cn) on August 30, 2025.
Voting results: 3 votes in favor, 0 votes against, 0 abstentions, and 0 avoidance votes.
(2) The meeting reviewed and approved the "Proposal of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Transfer of Partial Partnership Shares and Related Transactions of Partnership Enterprises".
In order to provide a comprehensive solution to the company's transfer of part of its shares in Chongqing Laimei Pharmaceutical Co., Ltd., the company plans to contribute 3.9 million yuan of partnership shares (actual investment 2,029.95) of Guangxi Lisui Investment Partnership (Limited Partnership) (hereinafter referred to as "Guangxi Lisui") held by Guangxi Haisheng Investment Management Co., Ltd. (hereinafter referred to as "Guangxi Haisheng") based on the assessed value. million) and Guangxi United Asset Management Co., Ltd. (hereinafter referred to as "United Asset Management") held a 66 million yuan partnership share in Guangxi Defu Investment Partnership (Limited Partnership) (hereinafter referred to as "Guangxi Defu"). The total transfer price of the above partnership shares was 100.68 million yuan.
In this transaction, the company has no related relationship with the transferors Guangxi Haisheng and United Asset Management. According to relevant regulations, Guangxi Guangtou Pharmaceutical and Health Industry Group Co., Ltd., the limited partner of Guangxi Lisui, is the company's related legal person, and Guangxi Financial Holding Asset Management Co., Ltd., the limited partner of Guangxi Defu, is the company's related legal person. Therefore, the company's transfer of part of the partnership share held by Guangxi Haisheng in Guangxi Lisui and the entire share held by Guangxi Defu by United Asset Management constitutes a related transaction of "joint investment between the listed company and related parties", but does not constitute a major asset reorganization as stipulated in the "Administrative Measures for Major Asset Reorganization of Listed Companies".
Related supervisor Ms. Wang Jian has abstained from voting.
Voting results: 2 votes in favor, 0 votes against, 0 abstentions, and 1 vote to avoid.
For details of this proposal, please refer to the "Announcement of Guangxi Wuzhou Zhongheng Group Co., Ltd. on the Transfer of Part of the Partnership Shares and Related Transactions of the Partnership" (announcement number: Lin 2025-77) disclosed on the Shanghai Stock Exchange website (www.sse.com.cn) on the same day.
3. Documents for reference
Resolution of the 16th meeting of the 10th Supervisory Board of Zhongheng Group.
Announcement is hereby made.
(No text below)
(This page has no text, it is only a stamped page of the "Announcement on Resolutions of the 16th Meeting of the 10th Supervisory Board of Guangxi Wuzhou Zhongheng Group Co., Ltd.")
Board of Supervisors of Guangxi Wuzhou Zhongheng Group Co., Ltd.
August 30, 2025